Analyst Price Targets — ELMD
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 11, 2026 1:13 pm | — | Roth Capital | $38.00 | $25.81 | TheFly | Electromed price target raised to $38 from $36 at Roth Capital |
| August 27, 2025 12:13 pm | Benjamin Haynor | Loop Capital Markets | $36.00 | $24.57 | StreetInsider | Lake Street Capital Markets Assumes Electromed (ELMD) at Buy |
| August 27, 2025 12:00 pm | Kyle Bauser | Roth Capital | $35.00 | $24.57 | TheFly | Electromed price target raised to $35 from $29 at Roth Capital |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for ELMD

Electromed (ELMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Electromed (ELMD) has delivered strong revenue growth and margin improvement, but faces a highly competitive, fragmented market for its SmartVest product. ELMD lacks a durable moat, with rivals like Tactile Medical and Baxter showing stronger brand recognition, technological advantages, and higher recent growth rates. Scientific evidence questions the comparative efficacy of HFCWO versus alternative airway clearance…

ISRG, EW and ELMD tap GenAI to enhance diagnostics and workflows, even as MedTech faces cost pressures, data risks and macro headwinds.

Electromed (ELMD) possesses solid growth attributes, which could help it handily outperform the market.

Electromed, Inc. (ELMD) Q2 2026 Earnings Call Transcript
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ELMD.
U.S. House Trading
No House trades found for ELMD.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
